BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023

Read original: arXiv:2407.08855 - Published 7/18/2024 by Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu, Debanjan Haldar, Zhifan Jiang, Anna Zapaishchykova, Julija Pavaine, Lubdha M. Shah, Blaise V. Jones, Nakul Sheth and 70 others
Total Score

0

BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • This paper presents the results of the BraTS-PEDs challenge, an international competition for segmenting pediatric brain tumors in medical imaging data.
  • The challenge involved segmenting different tumor regions, including the tumor core, enhancing tumor, and edema, in pediatric brain scans.
  • Participating teams developed advanced deep learning models to automatically identify and delineate these critical tumor regions, which is crucial for treatment planning and monitoring.

Plain English Explanation

The paper discusses the results of a competition called the BraTS-PEDs challenge, where researchers competed to create the best computer algorithms for identifying and outlining different parts of brain tumors in medical scans of children. Brain tumors are a serious health issue, and precisely mapping the various regions of a tumor is important for doctors to plan the best treatment and track how the tumor is responding over time.

The teams who participated in the challenge used sophisticated deep learning models - a type of artificial intelligence that can learn to recognize patterns in data. These models were trained on a large dataset of pediatric brain scans to teach them how to automatically detect and delineate key tumor regions, including the core of the tumor, areas with enhanced growth, and swollen brain tissue surrounding the tumor. The teams then submitted their models to be tested on a separate set of brain scans, and the performance of each model was evaluated.

The results of this international competition provide valuable insights into the current state-of-the-art in pediatric brain tumor segmentation using advanced AI techniques. The top-performing models demonstrate promising capabilities that could ultimately assist doctors in more accurately diagnosing and treating brain tumors in children.

Technical Explanation

The BraTS-PEDs challenge was an international competition focused on the task of automatically segmenting pediatric brain tumors in magnetic resonance imaging (MRI) data. Participating teams developed deep learning models to identify and delineate different tumor subregions, including the tumor core, enhancing tumor, and edema.

The challenge dataset consisted of multi-modal MRI scans of pediatric brain tumors, with expert-annotated ground truth segmentations. Teams trained their deep learning models on this dataset and submitted their results for evaluation on a held-out test set. The models were assessed on various segmentation metrics, including Dice similarity coefficient and Hausdorff distance, to measure how well the predicted segmentations aligned with the ground truth.

The top-performing teams demonstrated state-of-the-art performance in this challenging task, highlighting the potential of advanced deep learning techniques for assisting clinicians in the diagnosis and treatment planning of pediatric brain tumors. The insights gained from this competition can inform the development of more robust and reliable computer-aided tools for brain tumor analysis in the pediatric population.

Critical Analysis

The BraTS-PEDs challenge represents an important step forward in the application of deep learning for pediatric brain tumor segmentation. By focusing specifically on the unique characteristics and challenges of pediatric brain tumors, the competition has helped to advance the state-of-the-art in this critical domain.

One potential limitation of the research is the relatively small size of the dataset, which may limit the generalizability of the findings. The authors acknowledge this and suggest that further work is needed to validate the performance of these models on larger and more diverse datasets.

Additionally, while the top-performing models demonstrated impressive results, there is still room for improvement in terms of robustness and reliability. The authors note that the models may struggle with certain tumor types or imaging artifacts, and further research is needed to address these challenges.

Despite these caveats, the BraTS-PEDs challenge and its findings represent a significant contribution to the field of medical image analysis and computer-aided diagnosis. The insights gained from this competition can inform the development of more advanced and clinically-relevant tools for the assessment and management of pediatric brain tumors.

Conclusion

The BraTS-PEDs challenge has provided valuable insights into the current state-of-the-art in deep learning for pediatric brain tumor segmentation. The top-performing models demonstrated impressive capabilities in accurately identifying and delineating key tumor subregions, which could ultimately assist clinicians in more precise diagnosis, treatment planning, and disease monitoring.

While further research is needed to address the limitations and challenges highlighted in the paper, the results of this competition represent an important step forward in the application of advanced AI techniques to the field of pediatric neuro-oncology. As these technologies continue to evolve, they hold the promise of transforming the way brain tumors are detected, characterized, and managed, leading to better outcomes for young patients and their families.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023
Total Score

0

BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023

Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu, Debanjan Haldar, Zhifan Jiang, Anna Zapaishchykova, Julija Pavaine, Lubdha M. Shah, Blaise V. Jones, Nakul Sheth, Sanjay P. Prabhu, Aaron S. McAllister, Wenxin Tu, Khanak K. Nandolia, Andres F. Rodriguez, Ibraheem Salman Shaikh, Mariana Sanchez Montano, Hollie Anne Lai, Maruf Adewole, Jake Albrecht, Udunna Anazodo, Hannah Anderson, Syed Muhammed Anwar, Alejandro Aristizabal, Sina Bagheri, Ujjwal Baid, Timothy Bergquist, Austin J. Borja, Evan Calabrese, Verena Chung, Gian-Marco Conte, James Eddy, Ivan Ezhov, Ariana M. Familiar, Keyvan Farahani, Deep Gandhi, Anurag Gottipati, Shuvanjan Haldar, Juan Eugenio Iglesias, Anastasia Janas, Elaine Elaine, Alexandros Karargyris, Hasan Kassem, Neda Khalili, Florian Kofler, Dominic LaBella, Koen Van Leemput, Hongwei B. Li, Nazanin Maleki, Zeke Meier, Bjoern Menze, Ahmed W. Moawad, Sarthak Pati, Marie Piraud, Tina Poussaint, Zachary J. Reitman, Jeffrey D. Rudie, Rachit Saluja, MIcah Sheller, Russell Takeshi Shinohara, Karthik Viswanathan, Chunhao Wang, Benedikt Wiestler, Walter F. Wiggins, Christos Davatzikos, Phillip B. Storm, Miriam Bornhorst, Roger Packer, Trent Hummel, Peter de Blank, Lindsey Hoffman, Mariam Aboian, Ali Nabavizadeh, Jeffrey B. Ware, Benjamin H. Kann, Brian Rood, Adam Resnick, Spyridon Bakas, Arastoo Vossough, Marius George Linguraru

Pediatric central nervous system tumors are the leading cause of cancer-related deaths in children. The five-year survival rate for high-grade glioma in children is less than 20%. The development of new treatments is dependent upon multi-institutional collaborative clinical trials requiring reproducible and accurate centralized response assessment. We present the results of the BraTS-PEDs 2023 challenge, the first Brain Tumor Segmentation (BraTS) challenge focused on pediatric brain tumors. This challenge utilized data acquired from multiple international consortia dedicated to pediatric neuro-oncology and clinical trials. BraTS-PEDs 2023 aimed to evaluate volumetric segmentation algorithms for pediatric brain gliomas from magnetic resonance imaging using standardized quantitative performance evaluation metrics employed across the BraTS 2023 challenges. The top-performing AI approaches for pediatric tumor analysis included ensembles of nnU-Net and Swin UNETR, Auto3DSeg, or nnU-Net with a self-supervised framework. The BraTSPEDs 2023 challenge fostered collaboration between clinicians (neuro-oncologists, neuroradiologists) and AI/imaging scientists, promoting faster data sharing and the development of automated volumetric analysis techniques. These advancements could significantly benefit clinical trials and improve the care of children with brain tumors.

Read more

7/18/2024

🤖

Total Score

0

The Brain Tumor Segmentation in Pediatrics (BraTS-PEDs) Challenge: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)

Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu, Deep Gandhi, Zhifan Jiang, Syed Muhammed Anwar, Jake Albrecht, Maruf Adewole, Udunna Anazodo, Hannah Anderson, Ujjwal Baid, Timothy Bergquist, Austin J. Borja, Evan Calabrese, Verena Chung, Gian-Marco Conte, Farouk Dako, James Eddy, Ivan Ezhov, Ariana Familiar, Keyvan Farahani, Andrea Franson, Anurag Gottipati, Shuvanjan Haldar, Juan Eugenio Iglesias, Anastasia Janas, Elaine Johansen, Blaise V Jones, Neda Khalili, Florian Kofler, Dominic LaBella, Hollie Anne Lai, Koen Van Leemput, Hongwei Bran Li, Nazanin Maleki, Aaron S McAllister, Zeke Meier, Bjoern Menze, Ahmed W Moawad, Khanak K Nandolia, Julija Pavaine, Marie Piraud, Tina Poussaint, Sanjay P Prabhu, Zachary Reitman, Jeffrey D Rudie, Mariana Sanchez-Montano, Ibraheem Salman Shaikh, Nakul Sheth, Wenxin Tu, Chunhao Wang, Jeffrey B Ware, Benedikt Wiestler, Anna Zapaishchykova, Miriam Bornhorst, Michelle Deutsch, Maryam Fouladi, Margot Lazow, Leonie Mikael, Trent Hummel, Benjamin Kann, Peter de Blank, Lindsey Hoffman, Mariam Aboian, Ali Nabavizadeh, Roger Packer, Spyridon Bakas, Adam Resnick, Brian Rood, Arastoo Vossough, Marius George Linguraru

Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children. The five-year survival rate for high-grade gliomas in children is less than 20%. Due to their rarity, the diagnosis of these entities is often delayed, their treatment is mainly based on historic treatment concepts, and clinical trials require multi-institutional collaborations. Here we present the CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs challenge, focused on pediatric brain tumors with data acquired across multiple international consortia dedicated to pediatric neuro-oncology and clinical trials. The CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs challenge brings together clinicians and AI/imaging scientists to lead to faster development of automated segmentation techniques that could benefit clinical trials, and ultimately the care of children with brain tumors.

Read more

7/15/2024

Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge
Total Score

0

Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge

Dominic LaBella, Ujjwal Baid, Omaditya Khanna, Shan McBurney-Lin, Ryan McLean, Pierre Nedelec, Arif Rashid, Nourel Hoda Tahon, Talissa Altes, Radhika Bhalerao, Yaseen Dhemesh, Devon Godfrey, Fathi Hilal, Scott Floyd, Anastasia Janas, Anahita Fathi Kazerooni, John Kirkpatrick, Collin Kent, Florian Kofler, Kevin Leu, Nazanin Maleki, Bjoern Menze, Maxence Pajot, Zachary J. Reitman, Jeffrey D. Rudie, Rachit Saluja, Yury Velichko, Chunhao Wang, Pranav Warman, Maruf Adewole, Jake Albrecht, Udunna Anazodo, Syed Muhammad Anwar, Timothy Bergquist, Sully Francis Chen, Verena Chung, Gian-Marco Conte, Farouk Dako, James Eddy, Ivan Ezhov, Nastaran Khalili, Juan Eugenio Iglesias, Zhifan Jiang, Elaine Johanson, Koen Van Leemput, Hongwei Bran Li, Marius George Linguraru, Xinyang Liu, Aria Mahtabfar, Zeke Meier, Ahmed W. Moawad, John Mongan, Marie Piraud, Russell Takeshi Shinohara, Walter F. Wiggins, Aly H. Abayazeed, Rachel Akinola, Andr'as Jakab, Michel Bilello, Maria Correia de Verdier, Priscila Crivellaro, Christos Davatzikos, Keyvan Farahani, John Freymann, Christopher Hess, Raymond Huang, Philipp Lohmann, Mana Moassefi, Matthew W. Pease, Phillipp Vollmuth, Nico Sollmann, David Diffley, Khanak K. Nandolia, Daniel I. Warren, Ali Hussain, Pascal Fehringer, Yulia Bronstein, Lisa Deptula, Evan G. Stein, Mahsa Taherzadeh, Eduardo Portela de Oliveira, Aoife Haughey, Marinos Kontzialis, Luca Saba, Benjamin Turner, Melanie M. T. Bru{ss}eler, Shehbaz Ansari, Athanasios Gkampenis, David Maximilian Weiss, Aya Mansour, Islam H. Shawali, Nikolay Yordanov, Joel M. Stein, Roula Hourani, Mohammed Yahya Moshebah, Ahmed Magdy Abouelatta, Tanvir Rizvi, Klara Willms, Dann C. Martin, Abdullah Okar, Gennaro D'Anna, Ahmed Taha, Yasaman Sharifi, Shahriar Faghani, Dominic Kite, Marco Pinho, Muhammad Ammar Haider, Alejandro Aristizabal, Alexandros Karargyris, Hasan Kassem, Sarthak Pati, Micah Sheller, Michelle Alonso-Basanta, Javier Villanueva-Meyer, Andreas M. Rauschecker, Ayman Nada, Mariam Aboian, Adam E. Flanders, Benedikt Wiestler, Spyridon Bakas, Evan Calabrese

We describe the design and results from the BraTS 2023 Intracranial Meningioma Segmentation Challenge. The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas, which are typically benign extra-axial tumors with diverse radiologic and anatomical presentation and a propensity for multiplicity. Nine participating teams each developed deep-learning automated segmentation models using image data from the largest multi-institutional systematically expert annotated multilabel multi-sequence meningioma MRI dataset to date, which included 1000 training set cases, 141 validation set cases, and 283 hidden test set cases. Each case included T2, T2/FLAIR, T1, and T1Gd brain MRI sequences with associated tumor compartment labels delineating enhancing tumor, non-enhancing tumor, and surrounding non-enhancing T2/FLAIR hyperintensity. Participant automated segmentation models were evaluated and ranked based on a scoring system evaluating lesion-wise metrics including dice similarity coefficient (DSC) and 95% Hausdorff Distance. The top ranked team had a lesion-wise median dice similarity coefficient (DSC) of 0.976, 0.976, and 0.964 for enhancing tumor, tumor core, and whole tumor, respectively and a corresponding average DSC of 0.899, 0.904, and 0.871, respectively. These results serve as state-of-the-art benchmarks for future pre-operative meningioma automated segmentation algorithms. Additionally, we found that 1286 of 1424 cases (90.3%) had at least 1 compartment voxel abutting the edge of the skull-stripped image edge, which requires further investigation into optimal pre-processing face anonymization steps.

Read more

5/17/2024

The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI
Total Score

0

The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI

Maria Correia de Verdier, Rachit Saluja, Louis Gagnon, Dominic LaBella, Ujjwall Baid, Nourel Hoda Tahon, Martha Foltyn-Dumitru, Jikai Zhang, Maram Alafif, Saif Baig, Ken Chang, Gennaro D'Anna, Lisa Deptula, Diviya Gupta, Muhammad Ammar Haider, Ali Hussain, Michael Iv, Marinos Kontzialis, Paul Manning, Farzan Moodi, Teresa Nunes, Aaron Simon, Nico Sollmann, David Vu, Maruf Adewole, Jake Albrecht, Udunna Anazodo, Rongrong Chai, Verena Chung, Shahriar Faghani, Keyvan Farahani, Anahita Fathi Kazerooni, Eugenio Iglesias, Florian Kofler, Hongwei Li, Marius George Linguraru, Bjoern Menze, Ahmed W. Moawad, Yury Velichko, Benedikt Wiestler, Talissa Altes, Patil Basavasagar, Martin Bendszus, Gianluca Brugnara, Jaeyoung Cho, Yaseen Dhemesh, Brandon K. K. Fields, Filip Garrett, Jaime Gass, Lubomir Hadjiiski, Jona Hattangadi-Gluth, Christopher Hess, Jessica L. Houk, Edvin Isufi, Lester J. Layfield, George Mastorakos, John Mongan, Pierre Nedelec, Uyen Nguyen, Sebastian Oliva, Matthew W. Pease, Aditya Rastogi, Jason Sinclair, Robert X. Smith, Leo P. Sugrue, Jonathan Thacker, Igor Vidic, Javier Villanueva-Meyer, Nathan S. White, Mariam Aboian, Gian Marco Conte, Anders Dale, Mert R. Sabuncu, Tyler M. Seibert, Brent Weinberg, Aly Abayazeed, Raymond Huang, Sevcan Turk, Andreas M. Rauschecker, Nikdokht Farid, Philipp Vollmuth, Ayman Nada, Spyridon Bakas, Evan Calabrese, Jeffrey D. Rudie

Gliomas are the most common malignant primary brain tumors in adults and one of the deadliest types of cancer. There are many challenges in treatment and monitoring due to the genetic diversity and high intrinsic heterogeneity in appearance, shape, histology, and treatment response. Treatments include surgery, radiation, and systemic therapies, with magnetic resonance imaging (MRI) playing a key role in treatment planning and post-treatment longitudinal assessment. The 2024 Brain Tumor Segmentation (BraTS) challenge on post-treatment glioma MRI will provide a community standard and benchmark for state-of-the-art automated segmentation models based on the largest expert-annotated post-treatment glioma MRI dataset. Challenge competitors will develop automated segmentation models to predict four distinct tumor sub-regions consisting of enhancing tissue (ET), surrounding non-enhancing T2/fluid-attenuated inversion recovery (FLAIR) hyperintensity (SNFH), non-enhancing tumor core (NETC), and resection cavity (RC). Models will be evaluated on separate validation and test datasets using standardized performance metrics utilized across the BraTS 2024 cluster of challenges, including lesion-wise Dice Similarity Coefficient and Hausdorff Distance. Models developed during this challenge will advance the field of automated MRI segmentation and contribute to their integration into clinical practice, ultimately enhancing patient care.

Read more

5/29/2024